2Dyck PJ.Detection,characterization,and staging of polyneuropathy:assessed in diabetics.Muscle Nerve,1988,11:21-32.
3Forst T,Kann P,Pfutzner A,et al.Association between diabetic thick skin syndrome' and neurological disorders in diabetes.Acta Diabetol,1994,31:73-77.
4Ewing DJ,Martyn CN,Young RJ,et al.The evalue of cardiovascular automic function tests:10 year experience in diabetes.Diabetes Care,1985,8:491-498.
5Dyck PJ,Litchy WJ,Lehman KA,et al.Variables influencing neuropathic endpoints:the Rochester Diabetic Neuropathy Study of Healthy Subjects (RDNS-HS).Neurology,1995,45:1115-1120.
6Ambrosch A,Dierkes J,Lobmann R,et al.Relation between homocysteinaemia and diabetic neuropathy in patients with Type 2 diabetes mellitus.Diabetic Medicine,2001,18:185-192.
7Hofmann MA,Kohl B,Zumbach MS,et al.Hyperhomocysteinemia and endothelial dysfunction in IDDM.Diabetes Care,1998,21:841-848.
8Stracke H,Lindemann A,Federlin K,et al.A benfotiaminevitamin B combination in treatment of diabetic polyneuropathy.Exp Clin Endocrin Diab,1996,104:311-316.
9The Diabetes Control and Complications Trial Research Group.Factors in the development of diabetic neuropathy; baseline analysis of neuropathy in the feasibility phase of the Diabetes Control Complications Trial (DCCT).Diabetes,1988,37:476-481.
10The Diabetes and Complications Trial Research Group.The effect of intensive treatment of diabetes on the development of progression of long-term complications in insulin-dependent diabetes mellitus.N Engl J Med,1993,329:977-986.
